MatTek Life Sciences

This is a beginning of a new chapter for MatTek!

?? We’re thrilled to share the success of our 2-day seminar in Shanghai, hosted in collaboration with our partner, Cellex! The event's highlight was the traditional ribbon-cutting ceremony, symbolizing our official recognition by the Chinese scientific community. Over two days, 100 attendees explored MatTek’s innovative products, the latest advancements in standardization and validation, and key updates on New Approach Methodologies (NAMs) in China. Additionally, 15 scientists received hands-on training in the TG492 EpiOcular method, furthering our commitment to education and collaboration. A huge thank you to everyone who joined us—together, we’re driving progress in the scientific community! ???? #Innovation #ScientificCommunity #NAMs #MatTek #Collaboration

Our recent CELLEX-MatTek Life Sciences seminar was a huge success, celebrating the start of local production of our cutting-edge 3D models, EpiDerm, EpiOcular, and MelanoDerm. Over two inspiring days, more than 100 professionals joined us for the first day of conferences, and 15 scientists engaged in an in-depth training on the OECD TG492 method for ocular irritation at Cellex’s state-of-the-art labs. This event marks a powerful step forward in advancing NAMs availability in China. A big thank you to everyone who attended and contributed to this milestone moment! #betterscience #NAMs

Visikol advanced image and slide analysis services elevate your bioimaging research! From high-content screening to custom algorithm development, their expertise in quantitative imaging and high-performance analysis tools will help you extract crucial insights from even the largest datasets. Address complex imaging challenges, secure your data with advanced encryption, and receive clear, comprehensive reports. Let’s turn your data into actionable results. Learn more: https://bit.ly/3AjC06j

MatTek is exhibiting and presenting this week at the Association of Inhalation Toxicologists Annual Conference. Dr. Seyoum Ayehunie is presenting a poster on the development of multi-species airway tissue models. One of the challenges in the adoption of NAMs is the existence of large databases of animal toxicity data which are not directly translatable to data obtained from human in vitro airway tissue models due to species differences. To close that translational gap, Dr. Ayehunie and our R&D group have developed airway models from cells harvested from rats and non-human primates (NHP) to compare data to EpiAirway, MatTek's human airway model. These translational tools are vital to predicting airway inhalation toxicity and for bridging the in vitro-in vivo knowledge gap to reliably predict human responses, while providing an alternative approach to animal experimentation. Download the poster: https://bit.ly/3TxIbtV #betterscience #translationalbiology

MatTek scientists presented posters with new research at the EUROTOX Congress in Copenhagen, Denmark, last week. Posters include information on the development of our groundbreaking new EpiKidney tissue model, multi-species translational biology, and pre-validation of the EpiDerm model for skin sensitization. See what we've been working on and download copies of our posters: https://bit.ly/4emYDVK #betterscience #eurotox2024

?? Expanding Global Reach: MatTek Enters the Chinese Market through Strategic Partnership with CellEx I am thrilled to announce a groundbreaking partnership between MatTek Life Sciences and CellEx, a leading life sciences laboratory in China! This collaboration marks a significant milestone for MatTek as we license our cutting-edge in vitro human tissue technology to CellEx, enabling the production of our advanced tissue models within China. This strategic move not only expands our global footprint but also aligns with our mission to provide reliable, human-relevant testing solutions across the globe. By joining forces with CellEx, we are opening new doors for researchers and companies in China to access innovative tools for research, pharmaceutical development, and safety testing. Our partnership with CellEx represents a major step forward in meeting the growing demand for ethically produced, human-relevant tissue models in one of the world’s most dynamic markets, This collaboration is poised to drive innovation and foster the integration of Chinese tissue engineering technology with international standards, paving the way for significant advancements in the life sciences field. #LifeSciences #TissueEngineering #ResearchInnovation #MatTek #China?#Biotechnology

NEWS: We're thrilled to announce that MatTek has licensed its groundbreaking in vitro human tissue technology to CellEx, a leading life science laboratory in China. In alignment with our mission to expand access and to reliable 3D models worldwide, CellEx will produce our portfolio of organotypic human tissues using our proprietary technology. This strategic partnership marks a major milestone in expanding the global reach of our advanced tissue models, and enabling researchers in China to access superior, human-relevant solutions for research, pharmaceutical development, and safety assessments. Read more: https://bit.ly/4e9XkcO #betterscience #innovation

Our colleagues, Alonso Alain and Viktor Karetsky, participated in a seminar organized by Kurabo Industries LTD, our valued partner and distributor in Japan. This seminar gathered numerous attendees from various industries such as cosmetics, medical devices, and pharma. Viktor presented and led a discussion on our ongoing projects including the pre-validation of toxicity assays using our EpiVaginal and EpiAirway models, as well as development of MatTek’s new tissue models such as EpiLiver and EpiKidney. After the seminar a lively Q&A session took place. In the following days the MatTek and Kurabo team exhibited at the 2024 Japan Society of Toxicology meeting held in Fukuoka and presented a poster. We are always grateful for the chance to educate and inform others around the globe about the capabilities of our technology, and the future of testing! #betterscience #collaboration #japan

Want to know more about how in vitro science is bridging the gap between animal testing and human results? This article goes into greater detail about our work with Charles River Laboratories to develop a New Approach Methodology (NAM) inhalation toxicology test to reduce reliance on traditional animal research methods. #betterscience #NAMs